During the past decade, Obase Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Obase Hospital" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Obase Hospital" are "Osteoarthritis, Hip" (2 trials), "Osteoarthritis, Knee" (2 trials) and "Chronic Pain" (1 trials). Many other conditions were trialed in "Obase Hospital" in a lesser frequency.

Most popular intervention types in "Obase Hospital" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "NSAID" (1 trials), "Placebo" (1 trials), "Tanezumab" (1 trials), "Tanezumab 2.5 mg" (1 trials) and "Tanezumab 5 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Obase Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Obase Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Obase Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Obase Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".